Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Short-Term Debt issuances (2012 - 2014)

Updated

Marker Therapeutics (MRKR) posted Short-Term Debt issuances of $500.00 for Q1 2014.

Analysis

Marker Therapeutics (MRKR) Short-Term Debt issuances (2012 - 2014) Analysis & Trends

For FY2013, Marker Therapeutics' Short-Term Debt issuances came in at $32,200, up 973.3% from FY2012.

  • Annual Short-Term Debt issuances shows a three-year compound annual growth rate of -57.7% (FY2010 to FY2013).
  • In prior years, Marker Therapeutics' Short-Term Debt issuances was $3,000 in FY2012 and $425,000 in FY2010.
  • The Q1 2014 figure stands as the highest quarterly Short-Term Debt issuances since Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Marker Therapeutics 20.86 Mn -39.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 500.00
Dec 31, 2012 -18,000.00
Sep 30, 2012 3,000.00
API Access

Marker Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=MRKR&period=max&api_key=YOUR_API_KEY